Skip to main content
. 2023 Aug 4;102(31):e34501. doi: 10.1097/MD.0000000000034501

Table 1.

Patient baseline characteristics.

Variables Total, No. (%) Non-NAC, No. (%) NAC, No. (%) P value
Age, yr (median, IQR) 68 (61, 75) 69 (61, 75) 67 (59, 72) .073
Age, yr .224
 ≤70 750 (59.1%) 700 (58.7%) 50 (65.8%)
 >70 518 (40.9%) 492 (41.3%) 26 (34.2%)
Sex .418
 Male 1029 (81.2%) 970 (81.4%) 59 (77.6%)
 Female 239 (18.8%) 222 (18.6%) 17 (22.4%)
Race .121
 White 1134 (89.4%) 1062 (89.1%) 72 (94.7%)
 Other 134 (10.6%) 130 (10.9%) 4 (5.3%)
N stage <.001
 N0 1237 (97.6%) 1168 (98.0%) 69 (90.8%)
 N+ 31 (2.4%) 24 (2.0%) 7 (9.2%)
Size, mm .779
 <30 335 (26.4%) 316 (26.5%) 19 (25%)
 ≥30 348 (27.4%) 329 (27.6%) 19 (25%)
 Unknown 585 (46.1%) 547 (45.9%) 38 (50%)
Histology .009
 Urothelial 1206 (95.1%) 1139 (95.6%) 67 (88.2%)
 Non-urothelial 62 (4.9%) 53 (4.4%) 9 (11.8%)

IQR = interquartile range, NAC = neoadjuvant chemotherapy.